According to the new market research report "Protein Expression Market by Type (Escherichia Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus and Cell-free), Products (Reagents, Competent Cells, Instruments, Services), Application, End-User and Region - Global Forecast to 2025" published by MarketsandMarkets™.
- In 2020, Thermo Fisher Scientific Inc. acquired the biotechnology company, Qiagen (Germany). This acquisition will help Thermo Fisher Scientific to enhance its precision medicine portfolio through molecular diagnostics and improved life sciences solutions.
- In 2020, Merck announced plans for the construction of a new biotech development facility in Switzerland. The company will be investing USD 282.5 million for this purpose. This facility is going to strengthen the company’s presence in the protein expression market.
- In 2019, Agilent Technologies acquired BioTek Instruments (US). This acquisition expanded Agilent’s presence and expertise in cell analysis and strengthened its position in the growing immune-oncology and immunotherapy areas.
The prokaryotic expression systems segment accounted for the largest share of the protein expression market.
Based on system type, the market is segmented into prokaryotic expression systems, mammalian cell expression systems, insect cell expression systems, yeast expression systems, cell-free expression systems, and algal-based expression systems. The prokaryotic expression systems segment accounted for the largest share of the global protein expression market in 2019. The large share of this segment is attributed to the low cost and ease of use of prokaryotic expression systems.
The reagents segment accounted for the largest share of the protein expression industry in 2019.
Based on product and service, the protein expression industry is segmented into reagents, expression vectors, competent cells, instruments, and services. The reagents segment accounted for the largest share of the market in 2019. The large share of this segment is mainly due to the increasing research activities in the field of protein expression and the large-scale production of antibodies and vaccines.
In 2019, North America dominated the protein expression sector, followed by Europe. The major factors driving the growth of this market include the increasing incidence of chronic diseases, growth in the geriatric population, and increasing demand for protein biologics.
The prominent players in this market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Genscript Biotech Corporation (US), Takara Bio, Inc. (Japan), Bio-Rad Laboratories (US), Lonza (US), Promega Corporation (US), New England Biolabs (US), Oxford Expression Technologies Ltd. (US), and Synthetic Genomics Inc. (US).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: